Log In
Print this Print this

cordycepin (OVI-123), 3'-deoxyadenosine

  Manage Alerts
Collapse Summary General Information
Company OncoVista Innovative Therapies Inc.
DescriptionNucleoside analog
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationLeukemia
Indication DetailsTreat terminal deoxynucleotidyl transferase (TdT)-positive refractory leukemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today